BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maltas J, Reed H, Porter A, Malliri A. Mechanisms and consequences of dysregulation of the Tiam family of Rac activators in disease. Biochem Soc Trans 2020;48:2703-19. [PMID: 33200195 DOI: 10.1042/BST20200481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Payapilly A, Guilbert R, Descamps T, White G, Magee P, Zhou C, Kerr A, Simpson KL, Blackhall F, Dive C, Malliri A. TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change. Cell Rep 2021;37:109979. [PMID: 34758330 DOI: 10.1016/j.celrep.2021.109979] [Reference Citation Analysis]
2 Machin PA, Tsonou E, Hornigold DC, Welch HCE. Rho Family GTPases and Rho GEFs in Glucose Homeostasis. Cells 2021;10:915. [PMID: 33923452 DOI: 10.3390/cells10040915] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cooke M, Kreider-Letterman G, Baker MJ, Zhang S, Sullivan NT, Eruslanov E, Abba MC, Goicoechea SM, García-Mata R, Kazanietz MG. FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma. Cell Rep 2021;37:109905. [PMID: 34731623 DOI: 10.1016/j.celrep.2021.109905] [Reference Citation Analysis]
4 Porter AP, Reed H, White GRM, Ogg EL, Whalley HJ, Malliri A. The RAC1 activator Tiam1 regulates centriole duplication through controlling PLK4 levels. J Cell Sci 2021;134:jcs252502. [PMID: 33758078 DOI: 10.1242/jcs.252502] [Reference Citation Analysis]
5 Sauzeau V, Beignet J, Vergoten G, Bailly C. Overexpressed or hyperactivated Rac1 as a target to treat hepatocellular carcinoma. Pharmacol Res 2022;:106220. [PMID: 35405309 DOI: 10.1016/j.phrs.2022.106220] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]